"Adirondack Medical Research Center was founded in 2001 for the advancement of medical science in the Adirondack area of Upstate New York. The Founder and current Medical Director, Andrew W. Garner MD, CPI, FAPCR, has been a Certified Physician Investigator since 2012 with the Association of Clinical Research Professionals (ACRP) and is a Fellow of the Academy of Physicians in Clinical Research (APCR). As a Fellow of the APCR (FAPCR), Dr. Garner is recognized for demonstrating commitment to the organization, for achievements as a researcher and for leadership in the field of clinical research. Adirondack Medical Research Center is a multi-therapeutic research center performing phase II - IV studies in most therapeutic areas of medicine."

During the past decade, Adirondack Medical Research Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Adirondack Medical Research Center" #1 sponsor was "Celgene" with 3 trials, followed by "Avid Radiopharmaceuticals" with 2 trials sponsored, "AZTherapies, Inc." with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Oxford Immunotec" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Adirondack Medical Research Center" #1 collaborator was "APCER Life Sciences" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "KCAS Bio" with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "PharmaConsulting Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Adirondack Medical Research Center" are "Crohn Disease" (3 trials), "Alzheimer's Disease" (2 trials), "Alzheimer Disease" (1 trials), "Chronic Disease" (1 trials) and "Cognition Disorders" (1 trials). Many other conditions were trialed in "Adirondack Medical Research Center" in a lesser frequency.

Most popular intervention types in "Adirondack Medical Research Center" are "Drug" (8 trials), "Other" (3 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ozanimod" (3 trials), "Placebo" (3 trials), "ALZT-OP1a" (1 trials), "ALZT-OP1b" (1 trials) and "Flortaucipir F18" (1 trials). Other intervention names were less common.

The vast majority of trials in "Adirondack Medical Research Center" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Adirondack Medical Research Center". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Adirondack Medical Research Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Adirondack Medical Research Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".